NEW YORK (GenomeWeb News) – Cellectricon said today that the Automation Partnership will co-develop and manufacture Cellectricon’s DynaflowHT System, a high-throughput ion channel screening platform that the company plans to launch next year.
Cellectricon has been developing the Dynaflow HT platform, a cell-based microfluidics electrophysiology system, over the last three years in partnership with AstraZeneca.
Financial terms of the agreement with TAP were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.